Advertisement
News
Subscribe to MDT Magazine News

Biolase surges on strong 2011 revenue outlook

January 20, 2011 9:45 am | by The Associated Press | Comments

Shares of Biolase Technology Inc. nearly doubled in value Thursday after the dental laser company forecast much higher revenue in 2011 than Wall Street expected.Biolase expects $55 million to $60 million in revenue this year. Analysts forecast $40.4 million on average, according to estimates...

Vertex hepatitis C drug wins FDA priority review

January 20, 2011 9:39 am | by Mass High Tech: The Journal of New England Technology | Comments

Vertex Pharmaceuticals Inc. has won priority review from the U.S. Food and Drug Administration for its hepatitis C virus treatment, telaprevir. The drug is expected to receive an approval decision on May 23.

Anika Therapeutics appoints Thompson to board

January 20, 2011 9:38 am | by Mass High Tech: The Journal of New England Technology | Comments

Anika Therapeutics Inc., a Bedford-based tissue products company, has named to its board of directors Jeffrey Thompson, chairman and CEO of Advanced Bio-Technologies Inc., a scar treatment developer, in Georgia.

Advertisement

Stryker Corporation Named One of FORTUNE Magazine's '100 Best Companies to Work For'

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

KALAMAZOO, Mich.. Jan. 20, 2011 /- Stryker Corporation (NYSE: SYK ) announced today that it has been named one of the "100 Best Companies to Work For" by FORTUNE in the magazine's 14th annual survey of top-rated workplaces in the United States.  This is Stryker's first time to be...

TOPICS:

W. L. Gore & Associates Continues Its Tradition as One of Nation's Best Workplaces

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

NEWARK, Del., Jan. 20, 2011  /- With its unique, non-hierarchical, team-based culture, global manufacturing company W. L. Gore & Associates has once again earned a spot on FORTUNE magazine's annual list of the 100 Best Companies to Work for in America. The company is ranked No....

TOPICS:

TheCarrot.com Launches Quit Smoking Program

January 20, 2011 8:46 am | by Bio-Medicine.Org | Comments

SAN FRANCISCO, Jan. 20, 2011 /- TheCarrot.com , a leading provider of online and mobile consumer health engagement programs, announced the immediate availability of its new Quit Smoking Program. Drawing on the expertise of the University of California at San Francisco's Smoking Cessation...

TOPICS:

State of the Medicare Mobility Benefit

January 20, 2011 8:45 am | by Bio-Medicine.Org | Comments

WASHINGTON, Jan. 20, 2011 /PRNewswire-USNewswire/ -- The State of the Medicare Mobility Benefit has never been more troubling, and perplexing. For much of the last decade, Congress and regulators implemented policies and regulations limiting the effectiveness of the Medicare benefit that...

TOPICS:

Summary Box: UnitedHealth 4Q profit rises 10 pct

January 20, 2011 7:45 am | by The Associated Press | Comments

PROFIT GROWTH: UnitedHealth Group's fourth-quarter profit rose 10 percent to $1.04 billion, or 94 cents per share, compared with the same quarter of 2009. Revenue increased 10 percent to $24.03 billion.WALL STREET BEAT: Analysts polled by FactSet were expecting, on average, earnings of 84 cents per...

Advertisement

Genzyme expands Belgium manufacturing plant

January 20, 2011 6:50 am | by Mass High Tech: The Journal of New England Technology | Comments

Genzyme Corp. plans to build a manufacturing plant in Geel, Belgium, to aid growing production of its Pompe disease drug, Lumizyme, which had been produced in the company's Allston plant prior to its temporary shutdown in the summer of 2009.

Featured Search — The Value of Experience in Breast Cancer Diagnosis

January 20, 2011 6:33 am | by Diagnostic Imaging | Comments

Radiologists at Cambridge University Hospital found that more experienced radiologists are far better at detecting breast malignancy.

TOPICS:

InformexUSA 2011 Projects Record Attendance

January 20, 2011 5:48 am | by Bio-Medicine.Org | Comments

PRINCETON, N.J., Jan. 20, 2011 /- Informex , the leading meeting place for buyers and sellers of high-value chemistry for a broad range of applications, today announced projections that 2011 will be a record setting year for both attendee and exhibitor numbers at the brand's flagship...

TOPICS:

Pervasis to Present Interim Data from Phase 1/2 Clinical Study of Novel Cell Therapy Targeting Peripheral Artery Disease at International Conference on Cell Therapy for Cardio...

January 20, 2011 5:44 am | by Bio-Medicine.Org | Comments

CAMBRIDGE, Mass., Jan. 20, 2011 /- Pervasis Therapeutics, Inc. today announced it will present interim data from the company's Phase 1/2 clinical study of PVS-10200, an investigational cell-based therapy under development to prevent restenosis in patients with peripheral arterial disease...

TOPICS:

Earnings and jobless claims likely to sway stocks

January 20, 2011 4:45 am | by MATTHEW CRAFT - AP Business Writer - Associated Press | Comments

U.S. stocks appear headed for a mixed opening on Thursday, a day after weak earnings gave them their worst drubbing since November.Investors are getting a new round of corporate earnings and economic reports. The Labor Department said Thursday morning that first time claims for unemployment...

Ascension Orthopedics Introduces True Modularity With MOVEMENTâ„¢ Great Toe System

January 20, 2011 4:44 am | by Bio-Medicine.Org | Comments

AUSTIN, Texas, Jan. 20, 2011 /- Ascension Orthopedics, Inc., a leader in orthopedic extremity implants, announces the expansion of the MOVEMENT™ Great Toe Implant System to include a total arthroplasty component. This complete great toe arthroplasty system now allows surgeons the...

TOPICS:

Spherix Announces Registered Direct Offering of $2.77 Million

January 20, 2011 4:43 am | by Bio-Medicine.Org | Comments

BETHESDA, Md., Jan. 20, 2011 /- Spherix Incorporated (Nasdaq: SPEX ), an innovator in biotechnology for therapy in diabetes, metabolic syndrome and atherosclerosis; and providers of technical and regulatory consulting services to food, supplement, biotechnology and pharmaceutical...

TOPICS:

Pages

X
You may login with either your assigned username or your e-mail address.
The password field is case sensitive.
Loading